[IMCAS World 2026 Special] Shaping the Future: K-Medical Aesthetics Leading Innovation ⑩ | Interview with Minyoung Kim, CEO of FLAWLESS (WiQo's Exclusive Korean Distributor)
WiQo, an Italian medical aesthetics company pioneering a new category of non-invasive topical skin boosters based on TCA and HCA, drew significant attention at IMCAS World Congress 2026 with a dedicated booth showcasing its product lineup. PRX-PLUS has rapidly gained traction in the market with its topical-only mechanism that stimulates the dermis without needles or injection. Its application in melasma treatment, in particular, attracted strong interest from international practitioners as a novel, rebound-free approach. Global expansion has also been accelerating, with 18 new distributorships established over the past year, predominantly across Asia. Minyoung Kim, CEO of FLAWLESS, WiQo's exclusive Korean distributor, noted at the event in Paris: "This year, our focus is on leveraging PRX-PLUS for pigmentation treatment through what we call 'WiQo Toning,'" adding that "K-Medical Aesthetics is evolving beyond a trend leader into a true trend setter." #MedicalAestheticsNews #IMCAS2026 #PRXPLUS #WiQoToning
★ Article Link: https://www.aestheticnews.co.kr/news/articleView.html?idxno=11222

Comments
Post a Comment